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To the Editor, 
We are writing in response to the article written by Jochmans et al (1). The article is 
comprehensive review on the status of preservation and resuscitation techniques in kidney 
and liver transplantation. It highlights the need for dynamic techniques of preservation for 
higher risk kidney and liver grafts, detailing hypothermic and normothermic perfusion 
technologies. The review also documents a list of registered clinical trials of these novel 
techniques in kidney transplantation. Supplementary information (S1) also lists the planned 
or ongoing trials that are unregistered. The authors state that currently, there are no registered 
ongoing RCTs comparing preimplantation normothermic machine perfusion with static cold 
storage.  
We are currently conducting a multicentre randomised controlled trial of ex-vivo 
normothermic perfusion versus static cold storage in donation after circulatory death renal 
transplantation which is listed in the unregistered clinical trials supplementary information 
table 1. However, since the inscription of this review, the trial has opened and is registered 
(ISRCTN15821205). We believe it is important to highlight this and update the readers as it 
is the only trial of its kind in renal transplantation at the time of writing. The trial is led by the 
University of Cambridge and includes three other UK transplant centres, Newcastle, Guy’s 
Hospital and Edinburgh. The trial will recruit 400 patients and be completed in February 
2020. 
In addition, the review also comments on the ability to evaluate kidney function during 
normothermic perfusion and refers to our previous work in this area. We formulated a quality 
assessment score using a series of declined human kidneys based on the macroscopic 
appearance, level of renal blood flow and urine output during 60 minutes of normothermic 
perfusion (2).  The authors comment that ‘proof of concept of transplanting kidneys that are 
discarded and subsequently resuscitated by preimplantation normothermic perfusion has not 
yet been reported’. We have just had a case report accepted for publication in Am J 
Transplantation documenting the transplantation of a pair of discarded kidneys after 
assessment and resuscitation using normothermic perfusion. Again, we believe that it is 
important to update this review article. 
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